Boyd-Stearns syndrome: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' {{CZ}}, [[User:Raviteja Reddy Guddeti|Raviteja Guddeti, M.B.B.S.]][mailto:rgudetti@perfuse.org] | {{CMG}}; '''Associate Editor(s)-In-Chief:''' {{CZ}}, [[User:Raviteja Reddy Guddeti|Raviteja Guddeti, M.B.B.S.]][mailto:rgudetti@perfuse.org] | ||
Revision as of 21:19, 22 July 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Raviteja Guddeti, M.B.B.S.[3]
Overview
Boyd-Stearns syndrome is characterized by glycosuria, acidosis, albuminuria and hypochloremia.
Symptoms include rickets during infancy, short stature, low blood phosphate levels, malnutrition and osteoporosis.
References